APA (7th ed.) Citation

Stein Gold, L., Bissonnette, R., Forman, S., Zaenglein, A., Kuo, Y., Angel, B., . . . Paller, A. S. (2025). A Maximum-Use Trial of Ruxolitinib Cream in Children Aged 2–11 Years with Moderate to Severe Atopic Dermatitis: Ruxolitinib Cream: Pediatric Maximum-Use Trial: L. S. Gold et al. American Journal of Clinical Dermatology, 26(2), 275. https://doi.org/10.1007/s40257-024-00909-5

Chicago Style (17th ed.) Citation

Stein Gold, Linda, Robert Bissonnette, Seth Forman, Andrea Zaenglein, YuTzu Kuo, Brett Angel, Xuejun Chen, Howard Kallender, and Amy S. Paller. "A Maximum-Use Trial of Ruxolitinib Cream in Children Aged 2–11 Years with Moderate to Severe Atopic Dermatitis: Ruxolitinib Cream: Pediatric Maximum-Use Trial: L. S. Gold Et Al." American Journal of Clinical Dermatology 26, no. 2 (2025): 275. https://doi.org/10.1007/s40257-024-00909-5.

MLA (9th ed.) Citation

Stein Gold, Linda, et al. "A Maximum-Use Trial of Ruxolitinib Cream in Children Aged 2–11 Years with Moderate to Severe Atopic Dermatitis: Ruxolitinib Cream: Pediatric Maximum-Use Trial: L. S. Gold Et Al." American Journal of Clinical Dermatology, vol. 26, no. 2, 2025, p. 275, https://doi.org/10.1007/s40257-024-00909-5.